Language selection

Search

Details for: SALOFALK 500MG DELAYED RELEASE TABLETS USP

Company: APTALIS PHARMA CANADA ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02112787SALOFALKMESALAZINE500 MGTABLET (DELAYED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Mesalazine-containing products - Assessing the Potential Risk of Birth Defects

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: